[1] 沈渔邨.精神病学[M].北京:人民卫生出版社, 第5版, 2011: 946-948.
[2] Karin Friedli, Michael K Almond, Clara Day, et al. A study of sertraline in dialysis( ASSert ID ) : a protocol for a pilot randomized controlled trial of drug treatment for depression in patients undergoing haemodialysis[J]. BMC Nephrol, 2015, 16( 1) :172.
[3] B Lawrence Riggs, Sundeep Khosla, Elizabeth Atkinson, et al. Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency[J]. Osteoporos Int, 2003, 14(9): 728-733.
[4] 许超, 肖鲁伟, 童培建, 等. 骨质疏松症与抑郁症关系的研究进展[J].中国骨质疏松杂志, 2009, 15(9): 693-696.
[5] Mary A Whooley, Gregory E Simon. Managingdepression in medical outpatients[J]. N Eng J Med, 2001, 343(26): 1942-1950.
[6] G H Brundtland. World Health Organization (2001) The world health report2001—mental health: new understanding, new hope[J]. JAMA, 2001, 286(19):2391.
[7] Yasuo Suzuki, Yoichi IchiKawa, Eizo Saito, et al. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy[J]. Metabolism, 1983, 32(2): 151-156.
[8] Malik P, Gasser R W, Moncayo R C, et al. Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities[J]. Prog Neuro-psychopharmacol Biol Psychiatry, 2013, 44(1): 58-63.
[9] Giovanni Cizza. Major depressive disorder is a risk factor for lowbone mass, central obesity, and other medical conditions[J].Dialogues ClinNeurosci, 2011, 13(1): 73-87.
[10] Kai G Kahl, Sebastian Rudolf, Beate M Stoeckelhuber, et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and withoutcomorbid major depressive disorder[J]. Am J Psychiatry, 2005, 162(1): 168-174.
[11] Feng Liang, Samuel C Scherer, Boon yeow Tan, et al. Comorbid cognitive impairment and depression is a significant predictor of poor out comesin hip fracture rehabilitation[J]. Int Psychogeriatr, 2010, 22: 246-253.
[12] Gertrudis I J M Kempen, Robbert Sanderman, Winnie Scaf-Klomp, et al. The role of depressive symptoms in recovery from injuries to the extremities in older persons. A prospective study[J].Int J Geriatr Psychiatry, 2003, 18(1): 14-22.
[13] Susan K Brenneman, Elizabeth Barrett-Connor, Shiva G Sajjan, et al. Impact ofrecent fracture on health-related quality of life in postmenopausal women[J]. J Bone Miner Res, 2006, 21(6):809-816.
[14] Holmes J, House A. Psychiatric illness predicts poor outcome after surgery for hip fracture: A prospective cohort study[J]. Psychol Med, 2000, 30(4):921-929.
[15] Samuel Y S Wong, Lau·Henry Lynn, Leung·Jean Woo,·et al.Depression and bone mineral density: is there a relationship in elderly Asian men? [J]. Osteoporos Int, 2005, 16(6): 610–615.
[16] Thomas Steckler, Florian Holsboer, Johannes M H M Reul, et al. Glucocorticoids and depression[J]. Best Pract Res Clin Endocrinol Metab, 1999, 13(4):597–614.
[17] George P Chrousos, Philip W Gold. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis[J]. J Am Med Assoc, 1992, 267(9):1244–1252.
[18] Elizabeth Barrett-Connor, Denise G von Muhlen, Donna Kritz-Silverstein. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study[J]. J Clin Endocr Metab, 1999, 84(2): 573– 577.
[19] Slemenda C W, Longscope C, Zhou l, et al. Sex steroids and bone mass in older men[J]. J Clin Invest, 1997, 100(7):1755–1759.
[20] Gail A Greendale, Sharon Edelstein, Elizabeth Barrett-Connor. Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study[J]. J Bone Miner Res, 1997, 12(11):1833–1834.
[21] Alize J Ferrari, Fiona J Charlson, Rosana E Norman, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010[J]. PLoS Med, 2013, 10(11): e1001547.
[22] David Michelson, Constantine Stratakis, Lauren Hill, et al. Bone mineral density in women with depression[J]. N Eng J Med, 1996, 335:1176–1181.
[23] Andres Herran, Jose Amado, Maria Garcia-Unzueta, et al. Increased bone remodeling in ?rst-episode major depressive disorder[J]. Psychosom Med, 2000, 62(6):779–782.
[24] Licinio J, Wong M L. The role of in?ammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection[J]. Mol Psychiatry, 1999, 4(4):317–327.
[25] Andrew N Dentino, Carl F Pieper, K Murali K Rao, et al. Association of interleukin-6 and other biological variables with depression in older people living in the community[J]. J Am Geriatr Soc, 1999, 47(1):6–11.
[26] Kyriakos P Aloumanis. The "depressive" face of osteoporosis and the "osteoporotic" face of depression[J].Hormones (Athens), 2013, 12(3): 350-362. |